Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Ocular Aging

Current understanding

Age-related eye disease (AMD, glaucoma, diabetic retinopathy, cataract, dry eye) is increasingly framed as a tissue-context expression of four interacting aging hallmarks — mitochondrial dysfunction, loss of proteostasis, cellular senescence, and epigenetic drift — operating along distinct routes in the retinal pigment epithelium, trabecular meshwork, and retinal neurovascular unit [expert-opinion]. Emerging geroscience therapeutics (senolytics, mitochondria-targeted agents, NAD+ metabolism modulators, partial epigenetic reprogramming) are proposed as tissue-resilience approaches beyond symptomatic anti-VEGF/IOP-lowering standards-of-care [expert-opinion]. Human translation in the eye remains at the preclinical/early-translational stage, with local delivery and cell-type specificity as gating problems.

Evidence log

Open questions

Related

Contributing findings

pubmed review
The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.
01-jul-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18